Anika Therapeutics Inc. · NASDAQ:ANIK
Vanguard Capital Management LLC reported a 5.19% stake in Anika Therapeutics Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.19% stake in Anika Therapeutics Inc., 695,697 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.19%
- Shares
- 695,697
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.19% | 695,697 |
Source
Related
- Anika Therapeutics Inc.
- Vanguard Capital Management LLC
- Anika Therapeutics Inc. shareholders
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Henneman John B III · Jun 23, 2026
- Form 4 · Richard Stephen · Jun 23, 2026